HERMES: messenger for stroke interventional treatment

Lancet. 2016 Apr 23;387(10029):1695-7. doi: 10.1016/S0140-6736(16)00351-2. Epub 2016 Feb 18.

Authors

Keith W Muir¹, Philip White²

Affiliations

¹ Institute of Neuroscience & Psychology, University of Glasgow, Queen Elizabeth University Hospital, Glasgow G51 4TF, UK. Electronic address: keith.muir@glasgow.ac.uk.
² Institute of Neuroscience and Newcastle University Institute for Ageing, University of Newcastle, Newcastle upon Tyne, UK.

PMID: 26898854
DOI: 10.1016/S0140-6736(16)00351-2

No abstract available

Publication types

Comment

MeSH terms

Brain Ischemia / therapy*
Endovascular Procedures / methods*
Female
Fibrinolytic Agents / therapeutic use*
Humans
Male
Stroke / therapy*
Thrombectomy / methods*
Tissue Plasminogen Activator / therapeutic use*

Substances

Fibrinolytic Agents
Tissue Plasminogen Activator

Grants and funding

HTA/14/08/47/DH_/Department of Health/United Kingdom